Business Responsibility And Sustainability Report

Overview

The report presents Akums Drugs & Pharmaceuticals Limited's FY2024-25 consolidated BRSR disclosures across workforce, governance, and environmental performance. Scope 1 emissions were 41,385.11 MT CO2e, Scope 2 emissions were 1,14,101.23 MT CO2e, and Scope 3 emissions were 1,76,304.32 metric tonnes of CO2 equivalent across four categories. Total energy consumption was 10,68,818.03 GJ, water consumption was 10,99,200.29 KL, and waste generated was 8,954.78 MT. The report states that no current-year assurance was obtained and that specific ESG targets had not yet been set.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Chapter
Fiscal year: 2024-2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services